• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

血液透析期间高血压尿毒症患者体内的18-羟基-11-脱氧皮质酮

18-Hydroxy-11-deoxycorticosterone in hypertensive uremic patients during hemodialysis.

作者信息

Sparano F, Giaquinto G, Odoardi A, Mercuri M A, Tosti-Croce C, Sulon J, Sciarra F

出版信息

Horm Res. 1979;10(5):282-8. doi: 10.1159/000179009.

DOI:10.1159/000179009
PMID:457038
Abstract

The present study was carried out in 25 hypertensive uremic patients on regular 4 h dialysis, 3 times a week. Plasma 18-hydroxy-11-deoxycorticosterone (18-OH-DOC), aldosterone (PA) and corticosteroids were determined by radioimmunoassay and competitive protein binding technique before and at the end of the 1st, 2nd and 3rd hour of hemodialysis. Plasma 18-HD-DOC was normal before dialysis and did not change significantly during hemodialysis, whereas body fluids and electolytes decreased progressively. No correlation was observed between blood pressure and 18-OH-DOC during dialysis. 18-OH-DOC did not correlate with PA which decreases progressively during hemodialysis and was correlated to plasma corticosteroids only at the 3rd hour of dialysis, probably on account of the enhanced influence of ACTH on the adrenal cortex.

摘要

本研究对25例接受常规每周3次、每次4小时透析的高血压尿毒症患者进行。采用放射免疫分析法和竞争性蛋白结合技术,在血液透析前以及透析第1、2、3小时结束时测定血浆18-羟-11-脱氧皮质酮(18-OH-DOC)、醛固酮(PA)和皮质类固醇。透析前血浆18-HD-DOC正常,血液透析期间无显著变化,而体液和电解质逐渐减少。透析期间血压与18-OH-DOC之间未观察到相关性。18-OH-DOC与PA无相关性,PA在血液透析期间逐渐降低,仅在透析第3小时与血浆皮质类固醇相关,这可能是由于促肾上腺皮质激素(ACTH)对肾上腺皮质的影响增强所致。

相似文献

1
18-Hydroxy-11-deoxycorticosterone in hypertensive uremic patients during hemodialysis.血液透析期间高血压尿毒症患者体内的18-羟基-11-脱氧皮质酮
Horm Res. 1979;10(5):282-8. doi: 10.1159/000179009.
2
Diurnal 18-hydroxy-11-deoxycorticosterone pattern in human stable hypertension.
J Clin Endocrinol Metab. 1978 Oct;47(4):829-33. doi: 10.1210/jcem-47-4-829.
3
Inappropriate elevation of the aldosterone/plasma renin activity ratio in hypertensive patients with increases of 11-deoxycorticosterone and 18-hydroxy-11-deoxycorticosterone: a subtype of essential hypertension?醛固酮/血浆肾素活性比值在高血压患者中不适当升高,同时伴有11-脱氧皮质酮和18-羟基-11-脱氧皮质酮升高:原发性高血压的一种亚型?
Cardiology. 1991;78(2):99-110. doi: 10.1159/000174773.
4
Simultaneous determination of plasma 11-deoxycorticosterone, 18-hydroxy-11-deoxycorticosterone, and aldosterone in man.
Tohoku J Exp Med. 1978 Apr;124(4):367-79. doi: 10.1620/tjem.124.367.
5
Role of 18-hydroxy-11-deoxycorticosterone and 16 alpha, 18-dihydroxy-11-deoxycorticosterone in hypertension.18-羟基-11-脱氧皮质酮和16α,18-二羟基-11-脱氧皮质酮在高血压中的作用
Mayo Clin Proc. 1977 May;52(5):317-22.
6
24 hour profile of 18-hydroxy-11-deoxycorticosterone in normal supine man: relationship with cortisol and aldosterone.正常仰卧男性18-羟基-11-脱氧皮质酮的24小时变化曲线:与皮质醇和醛固酮的关系
Clin Endocrinol (Oxf). 1978 May;8(5):367-72. doi: 10.1111/j.1365-2265.1978.tb02170.x.
7
The regulation of plasma 18-hydroxy 11-deoxycorticosterone in man.人体血浆18-羟基-11-脱氧皮质酮的调节
J Clin Invest. 1976 Jul;58(1):221-9. doi: 10.1172/JCI108453.
8
Plasma levels of 18-hydroxy-11-deoxycorticosterone in essential hypertension.
Endocrinol Jpn. 1978 Jun;25(3):237-43. doi: 10.1507/endocrj1954.25.237.
9
Relationship of 19-nor-deoxycorticosterone to other mineralocorticoids in low-renin hypertension.
Hypertension. 1983 May-Jun;5(3):385-9. doi: 10.1161/01.hyp.5.3.385.
10
Simultaneous determination of plasma aldosterone, corticosterone, 11-deoxycorticosterone, 18-hydroxydeoxycorticosterone, cortisol, and 11-deoxycortisol. Methods and applications.
Am J Clin Pathol. 1976 Sep;66(3):588-97. doi: 10.1093/ajcp/66.3.588.